Proactive Investors - Run By Investors For Investors

ReNeuron Group encouraged by level of interest in its key programmes

ReNeuron Group PLC's (LON:RENE) Michael Hunt chats to Proactive London's Andrew Scott following the release of its year-end update.

The cell therapy specialist has two clinical trials underway and is looking at partnerships or licensing deals for its three major programmes.

Hunt says with a partnership deal for its cell technology in China now secured they're pursuing other collaborations or out-licensing deals across all its programmes.

 
Meet Rockfire Resources PLC, Touchstone Exploration Inc, Mkango Resources Ltd and Salt Lake Potash Ltd at our event, London , 20 June 2019. Register here »
View full RENE profile View Profile

ReNeuron Group PLC Timeline

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use